Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 2, 2013, Pages 233-240

  Barzilay, Joshua I ^a   Gao, Peggy ^b   Clase, Catherine M ^c   Mente, Andrew ^b,c   Mann, Johannes F E ^d,e   Sleight, Peter ^f   Yusuf, Salim ^b,c   Teo, Koon K ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Kuratorium fuer Heimdialyse Kidney Center   (Germany)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; RAMIPRIL; TELMISARTAN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIP FRACTURE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PELVIS FRACTURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

EID: 84875030850     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06640712     Document Type: Article

References (28)

1. Brandi ML, Collin-Osdoby P: Vascular biology and the skeleton. J Bone Miner Res 21: 183-192, 2006
2. Parfitt AM: The mechanism of coupling: A role for the vasculature. Bone 26: 319-323, 2000
3. Laroche M, Ludot I, Thiechart M, Arlet J, Pieraggi M, Chiron P, Moulinier L, Cantagrel A, Puget J, Utheza G, Mazieres B: Study of the intraosseous vessels of the femoral head in patients with fractures of the femoral neck or osteoarthritis of the hip. Osteoporos Int 5: 213-217, 1995
4. Garg AX, Kiberd BA, ClarkWF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int 61: 2165-2175, 2002
5. Satchell SC, Tooke JE: What is the mechanism of microalbuminuria in diabetes: A role for the glomerular endothelium? Diabetologia 51: 714-725, 2008
6. Jørgensen L, Jenssen T, Ahmed L, Bjørnerem A, Joakimsen R, Jacobsen BK: Albuminuria and risk of nonvertebral fractures. Arch Intern Med 167: 1379-1385, 2007
7. Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, Hilbrich L, Pogue J, Schumacher H; ONTARGET/TRANSCEND Investigators;: Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 148: 52-61, 2004
8. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C; ONTARGET Investigators;: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358: 1547-1559, 2008
9. Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P; Telmisartan Randomised AssessmeNt Study in ACEiNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators;: Effects of the angiotensinreceptor blocker telmisartan on cardiovascular events in highrisk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet 372: 1174-1183, 2008
10. Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P; Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators;: Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomized controlled trial. Lancet 372: 1174-1183, 2008
11. Soares AA, Eyff TF, Campani RB, Ritter L, Camargo JL, Silveiro SP: Glomerular filtration rate measurement and prediction equations. Clin Chem Lab Med 47: 1023-1032, 2009
12. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX: Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6: 2634-2641, 2011
13. Eastell R, Newman C, Crossman DC: Cardiovascular disease and bone. Arch Biochem Biophys 503: 78-83, 2010
14. Burkhardt R, Kettner G, Böhm W, Schmidmeier M, Schlag R, Frisch B, Mallmann B, Eisenmenger W, Gilg T: Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8: 157-164, 1987
15. Prisby RD, RamseyMW, Behnke BJ, Dominguez JM2nd, Donato AJ, Allen MR, Delp MD: Aging reduces skeletal blood flow, endothelium-dependent vasodilation, and NO bioavailability in rats. J Bone Miner Res 22: 1280-1288, 2007
16. Griffith JF, Yeung DKW, Antonio GE, Lee FKH, Hong AWL, Wong SYS, Lau EMC, Leung PC: Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: Dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 236: 945-951, 2005
17. Shih TTF, Liu HC, Chang CJ, Wei SY, Shen LC, Yang PC: Correlation of MR lumbar spine bone marrow perfusion with bone mineral density in female subjects. Radiology 233: 121-128, 2004
18. Griffith JF, Yeung DK, Tsang PH, Choi KC, Kwok TC, Ahuja AT, Leung KS, Leung PC: Compromised bone marrow perfusion in osteoporosis. J Bone Miner Res 23: 1068-1075, 2008
19. Griffith JF, Wang YX, Zhou H, Kwong WH, Wong WT, Sun YL, Huang Y, Yeung DK, Qin L, Ahuja AT: Reduced bone perfusion in osteoporosis: Likely causes in an ovariectomy rat model. Radiology 254: 739-746, 2010
20. Pietschmann P, Schernthaner G, Woloszczuk W: Serum osteocalcin levels in diabetes mellitus: Analysis of the type of diabetes and microvascular complications. Diabetologia 31: 892-895, 1988
21. Mathiassen B, Nielsen S, Johansen JS, Hartwell D, Ditzel J, Rødbro P, Christiansen C: Long-term bone loss in insulindependent diabetic patients with microvascular complications. J Diabet Complications 4: 145-149, 1990
22. Jehle PM, Jehle DR, Mohan S, Böhm BO: Serum levels of insulinlike growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol 159: 297-306, 1998
23. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM: The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The cardiovascular health study. Am J Kidney Dis 44: 25-34, 2004
24. Syed FA, Ng AC: The pathophysiology of the aging skeleton. Curr Osteoporos Rep 8: 235-240, 2010
25. Aso Y, Inukai T, Tayama K, Takemura Y: Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis aswell as diabeticmicroangiopathy in patients with type 2 diabetes. Acta Diabetol 37: 87-92, 2000
26. Vashishth D: Advanced glycation end-products and bone fractures. IBMS BoneKEy 6: 268-278, 2009
27. Merlotti D, Gennari L, Dotta F, Lauro D, Nuti R: Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis 20: 683-690, 2010
28. Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P: Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol 22: 2322-2331, 2011